Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Catalyst Pharmaceuticals, Inc. (CPRX)
USD31.49
+0.01 (+0.03%)
US NASDAQ Healthcare Biotechnology
Address
355 Alhambra Circle 33134
Coral Gables, FL, US
Coral Gables, FL, US
CEO
Richard John Daly
Website
catalystpharma.com
IPO
2006-11-08
CIK 1369568 ISIN US14888U1016
Description
Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables, Florida, operates as a commercial-stage biopharmaceutical enterprise. This company is dedicated to discovering, developing, and marketing therapeutic solutions for individuals in the United States who are afflicted with uncommon, severe, and long-term neuromuscular and neurological disorders. Among its key offerings is Firdapse, an amifampridine phosphate tablet formulation approved for managing Lambert-Eaton Myasthenic Syndrome (LEMS). Catalyst also provides Ruzurgi, a specific treatment option for pediatric patients diagnosed with LEMS. Beyond its existing products, Catalyst is actively investigating additional applications for Firdapse, including its potential use in treating MuSK antibody positive myasthenia gravis, spinal muscular atrophy type 3, and hereditary neuropathy with liability to pressure palsies. The company engages in various strategic collaborations, such as licensing agreements with BioMarin Pharmaceutical Inc., and a joint development and commercialization agreement with Endo Ventures Limited concerning a generic version of Sabril tablets. Previously known as Catalyst Pharmaceutical Partners, Inc., the company adopted its current name in May 2015.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD31.49
+0.01 (+0.03%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.74
Float Shares
115.33M
Free Float %
94.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.03% | +0.00% | +22.89% | +27.99% | +35.27% | +33.42% | +31.67% | +136.99% | +525.30% | +5,372.76% | +410.49% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (16 ratings, all time)
Buy
Price Targets & DCF
Current price
31.49
Low
32.00
+1.6%
Consensus
32.00
+1.6%
Median
32.00
+1.6%
High
32.00
+1.6%
DCF (Unlevered)
148.21
+370.7%
DCF (Levered)
222.31
+606.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
64% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 7 | 0 |
| Hold | 4 | +4 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
32.00
+1.6%
|
| Last Quarter | 1 |
32.00
+1.6%
|
| Last Year | 2 |
32.50
+3.2%
|
| All Time | 11 |
24.77
-21.3%
|
Quality scores
Altman Z-Score
19.77
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
7 / 10
Strong MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
2 / 5
Medium
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
4 / 5
High
P/E Score
3 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+19.8% ★ Q1'26: +5.6% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+28.2% Q1'26: +11.1% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%+32.4% Q1'26: +39.9% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%+48.1% ★ Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%+86.5% ★ Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+1.9% ★ Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.01× ★ Q1'26: 0.01× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 4 EPS Ana. |
Dec 2027 5 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 2 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
102.31M
est: 101.58M (+0.7%)
|
119.07M
est: 118.12M (+0.8%)
|
140.83M
est: 140.71M (+0.1%)
|
214.20M
est: 211.57M (+1.2%)
|
398.20M
est: 434.48M (-8.3%)
|
491.73M
est: 483.82M (+1.6%)
|
588.99M
est: 579.10M (+1.7%)
|
632.92M
626.60M – 636.50M
+9.3% YoY
|
703.09M
684.24M – 718.03M
+11.1% YoY
|
765.95M
765.95M – 765.95M
+8.9% YoY
|
843.76M
810.83M – 861.94M
+10.2% YoY
|
894.38M
859.47M – 913.65M
+6.0% YoY
|
| EBITDA |
31.88M
est: 40.15M (-20.6%)
|
41.40M
est: 46.69M (-11.3%)
|
52.58M
est: 55.62M (-5.5%)
|
103.08M
est: 83.63M (+23.3%)
|
119.69M
est: 188.89M (-36.6%)
|
232.90M
est: 210.34M (+10.7%)
|
321.01M
est: 251.77M (+27.5%)
|
275.17M
272.42M – 276.72M
+9.3% YoY
|
305.67M
297.48M – 312.17M
+11.1% YoY
|
333.00M
333.00M – 333.00M
+8.9% YoY
|
366.83M
352.51M – 374.73M
+10.2% YoY
|
388.84M
373.66M – 397.21M
+6.0% YoY
|
| EBIT |
31.82M
est: 36.75M (-13.4%)
|
41.30M
est: 42.74M (-3.4%)
|
52.39M
est: 50.91M (+2.9%)
|
101.84M
est: 76.55M (+33.0%)
|
86.81M
est: 168.89M (-48.6%)
|
195.12M
est: 188.07M (+3.8%)
|
283.52M
est: 225.11M (+25.9%)
|
246.03M
243.57M – 247.42M
+9.3% YoY
|
273.30M
265.97M – 279.11M
+11.1% YoY
|
297.74M
297.74M – 297.74M
+8.9% YoY
|
327.98M
315.18M – 335.05M
+10.2% YoY
|
347.66M
334.09M – 355.15M
+6.0% YoY
|
| Net Income |
31.88M
est: 41.44M (-23.1%)
|
74.98M
est: 86.21M (-13.0%)
|
39.48M
est: 49.73M (-20.6%)
|
83.08M
est: 91.58M (-9.3%)
|
71.41M
est: 76.50M (-6.7%)
|
163.89M
est: 153.57M (+6.7%)
|
214.33M
est: 214.33M (+0.0%)
|
232.41M
228.87M – 259.56M
+8.4% YoY
|
269.72M
250.29M – 308.52M
+16.1% YoY
|
272.82M
240.52M – 328.33M
+1.1% YoY
|
318.14M
302.00M – 327.06M
+16.6% YoY
|
343.60M
326.16M – 353.22M
+8.0% YoY
|
| SGA |
36.88M
est: 34.29M (+7.6%)
|
44.23M
est: 39.87M (+10.9%)
|
49.63M
est: 47.49M (+4.5%)
|
57.09M
est: 71.41M (-20.1%)
|
133.71M
est: 142.95M (-6.5%)
|
177.74M
est: 159.19M (+11.7%)
|
193.75M
est: 190.53M (+1.7%)
|
208.24M
206.16M – 209.42M
+9.3% YoY
|
231.33M
225.13M – 236.24M
+11.1% YoY
|
252.01M
252.01M – 252.01M
+8.9% YoY
|
277.61M
266.78M – 283.59M
+10.2% YoY
|
294.27M
282.78M – 300.61M
+6.0% YoY
|
| EPS |
0.31
est: 0.33 (-6.5%)
|
0.72
est: 0.69 (+4.3%)
|
0.38
est: 0.40 (-4.5%)
|
0.80
est: 0.73 (+9.0%)
|
0.67
est: 0.61 (+10.2%)
|
1.38
est: 1.22 (+13.5%)
|
1.75
est: 1.61 (+8.4%)
|
1.92
1.80 – 2.04
+19.1% YoY
|
2.24
1.97 – 2.42
+16.5% YoY
|
2.24
1.89 – 2.58
-0.2% YoY
|
2.50
2.37 – 2.57
+11.9% YoY
|
2.70
2.56 – 2.78
+8.0% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-08 | Citigroup | Buy | Neutral | Downgrade |
| 2026-05-07 | Stephens & Co. | Overweight | Equal Weight | Downgrade |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 4/5 | 3/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 4/5 | 3/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 4/5 | 3/5 | 2/5 |
| 2026-05-06 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 4/5 | 3/5 | 2/5 |
| 2026-05-05 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-04 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-01 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-29 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-15 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
208.70M
OE per share TTM
1.64
Owner's Yield
5.48%
Maintenance CapEx ratio
0.07%
Maint CapEx / Avg PPE
0.9%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
174
Total invested
587.24M
Insider transactions (90d)
0
Beneficial owners (>5%)
21
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 15.27M | 14.90% | 15.15M | — | 15.27M | — | HC | Delaware | 2022-10-07 | ↗ |
| 2 | Armistice Capital, LLC | 9.57M | 9.30% | — | 9.57M | — | 9.57M | IA, OO | Delaware | 2022-02-15 | ↗ |
| 3 | Steven Boyd | 9.57M | 9.30% | — | 9.57M | — | 9.57M | HC, IN | Delaware | 2022-02-15 | ↗ |
| 4 | The Vanguard Group - 23-1945930 | 6.77M | 6.50% | — | 166.1K | 6.52M | 246.7K | IA | Pennsylvania | 2023-02-09 | ↗ |
| 5 | Deerfield Mgmt, L.P. | 6.06M | 5.82% | — | 6.06M | — | 6.06M | PN | Delaware | 2022-11-14 | ↗ |
| 6 | STATE STREET CORPORATION | 5.69M | 4.80% | — | 5.25M | — | — | HC | MA | 2024-10-17 | ↗ |
| 7 | Dr. Jeffrey R. Jay, M.D. | 3.82M | 3.73% | — | 3.82M | — | 3.82M | IN | USA | 2018-02-14 | ↗ |
| 8 | Great Point Partners, LLC | 3.82M | 3.73% | — | 3.82M | — | 3.82M | IA | USA | 2018-02-14 | ↗ |
| 9 | Mr. David Kroin | 3.82M | 3.73% | — | 3.82M | — | 3.82M | IN | USA | 2018-02-14 | ↗ |
| 10 | Telkoor Telecom Ltd. | 3.15M | 49.10% | — | 5.38M | — | 5.38M | CO | Delaware | 2020-03-26 | ↗ |
| 11 | Baker Bros. Advisors (GP) LLC | 2.90M | 2.80% | 2.90M | — | 2.90M | — | HC, OO | Delaware | 2019-02-13 | ↗ |
| 12 | Baker Bros. Advisors LP | 2.90M | 2.80% | 2.90M | — | 2.90M | — | IA, PN | Delaware | 2019-02-13 | ↗ |
| 13 | Felix J. Baker | 2.90M | 2.80% | 2.90M | — | 2.90M | — | HC, IN | United States | 2019-02-13 | ↗ |
| 14 | Julian C. Baker | 2.90M | 2.80% | 2.90M | — | 2.90M | — | HC, IN | United States | 2019-02-13 | ↗ |
| 15 | Broadfin Capital, LLC | — | 0.00% | — | — | — | — | IA, OO | Delaware | 2020-02-13 | ↗ |
| 16 | Broadfin Healthcare Master Fund, Ltd. | — | 0.00% | — | — | — | — | CO | Delaware | 2020-02-13 | ↗ |
| 17 | Consonance Capital Management LP | — | 0.00% | — | — | — | — | IA, PN | Delaware USA | 2020-01-09 | ↗ |
| 18 | Consonance Capital Opportunity Fund Management LP | — | 0.00% | — | — | — | — | IA, PN | Delaware USA | 2020-01-09 | ↗ |
| 19 | Consonance Capman GP LLC | — | 0.00% | — | — | — | — | HC, OO | Delaware USA | 2020-01-09 | ↗ |
| 20 | Kevin Kotler | — | 0.00% | — | — | — | — | HC, IN | Delaware | 2020-02-13 | ↗ |
| 21 | Mitchell Blutt | — | 0.00% | — | — | — | — | HC, IN | Delaware USA | 2020-01-09 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
174
-202 vs prev Q
New positions
26
Closed positions
224
Increased
86
Reduced
48
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 778.6K +778.6K (+100.0%) | 18.17B +18.2B (+100.0%) | 0.64% +0.635 pp | 0.03% +0.027 pp | USD23.34 +0.0% | 1 qtrs NEW |
| 2 | BLACKROCK, INC. | 18.63M +410.7K (+2.3%) | 434.75M +75.9M (+21.1%) | 15.19% +0.282 pp | 0.01% +0.001 pp | USD19.99 +16.8% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 8.43M -281.3K (-3.2%) | 196.81M +25.2M (+14.7%) | 6.88% -0.255 pp | 0.00% +0.000 pp | USD8.94 +161.1% | 61 qtrs — |
| 4 | STATE STREET CORP | 6.91M +502.2K (+7.8%) | 161.22M +35.0M (+27.8%) | 5.63% +0.391 pp | 0.01% +0.001 pp | USD12.26 +90.4% | 49 qtrs — |
| 5 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4.91M -63.6K (-1.3%) | 114.63M +16.6M (+17.0%) | 4.01% -0.066 pp | 1.46% -0.032 pp | USD17.52 +33.2% | 14 qtrs — |
| 6 | FUNDSMITH LLP | 3.36M +— (+0.0%) | 78.51M +12.2M (+18.5%) | 2.74% -0.010 pp | 0.46% +0.124 pp | USD22.94 +1.7% | 4 qtrs — |
| 7 | AMERICAN CENTURY COMPANIES INC | 3.03M +497.1K (+19.7%) | 70.61M +20.8M (+41.8%) | 2.47% +0.398 pp | 0.04% +0.010 pp | USD21.23 +9.9% | 23 qtrs — |
| 8 | DIMENSIONAL FUND ADVISORS LP | 3.00M +538.1K (+21.9%) | 69.93M +21.5M (+44.4%) | 2.44% +0.432 pp | 0.01% +0.004 pp | USD13.04 +79.0% | 30 qtrs — |
| 9 | MORGAN STANLEY | 2.93M +1.1M (+59.1%) | 68.47M +32.1M (+88.5%) | 2.39% +0.884 pp | 0.00% +0.002 pp | USD20.43 +14.2% | 49 qtrs — |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.90M +10.0K (+0.3%) | 67.70M +10.8M (+18.9%) | 2.37% 0.000 pp | 0.00% +0.001 pp | USD9.23 +152.9% | 57 qtrs — |
| 11 | RENAISSANCE TECHNOLOGIES LLC | 2.65M -894.8K (-25.2%) | 61.85M -8.0M (-11.4%) | 2.16% -0.740 pp | 0.10% +0.004 pp | USD15.99 +46.0% | 18 qtrs — |
| 12 | BANK OF AMERICA CORP /DE/ | 2.20M -91.6K (-4.0%) | 51.34M +6.2M (+13.7%) | 1.79% -0.081 pp | 0.00% +0.001 pp | USD20.24 +15.3% | 52 qtrs — |
| 13 | ROYCE & ASSOCIATES LP | 1.91M -124.2K (-6.1%) | 44.60M +4.5M (+11.2%) | 1.56% -0.107 pp | 0.45% +0.053 pp | USD13.26 +76.0% | 25 qtrs — |
| 14 | JANUS HENDERSON GROUP PLC | 1.72M +1.1M (+200.6%) | 40.12M +28.8M (+255.9%) | 1.40% +0.934 pp | 0.02% +0.013 pp | USD22.11 +5.6% | 19 qtrs — |
| 15 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.62M +312.4K (+23.9%) | 37.75M +12.0M (+46.8%) | 1.32% +0.251 pp | 0.02% +0.006 pp | USD21.90 +6.6% | 12 qtrs — |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.36M +24.5K (+1.8%) | 31.66M +5.4M (+20.7%) | 1.11% +0.016 pp | 0.00% +0.001 pp | USD11.10 +110.3% | 35 qtrs — |
| 17 | INVESCO LTD. | 1.29M +60.2K (+4.9%) | 30.19M +5.9M (+24.3%) | 1.06% +0.046 pp | 0.00% +0.001 pp | USD15.56 +50.0% | 26 qtrs — |
| 18 | BOSTON PARTNERS | 1.23M -59.7K (-4.6%) | 28.54M +3.0M (+11.6%) | 1.00% -0.053 pp | 0.03% +0.003 pp | USD16.11 +44.9% | 16 qtrs — |
| 19 | NORTHERN TRUST CORP | 1.21M -51.9K (-4.1%) | 28.29M +3.4M (+13.6%) | 0.99% -0.046 pp | 0.00% +0.000 pp | USD5.81 +301.7% | 51 qtrs — |
| 20 | KENNEDY CAPITAL MANAGEMENT LLC | 1.21M +149.5K (+14.1%) | 28.23M +7.3M (+35.2%) | 0.99% +0.119 pp | 0.60% +0.136 pp | USD16.08 +45.1% | 11 qtrs — |
| 21 | MILLENNIUM MANAGEMENT LLC | 993.6K -185.5K (-15.7%) | 23.19M -38.2K (-0.2%) | 0.81% -0.155 pp | 0.01% 0.000 pp | USD19.52 +19.6% | 26 qtrs — |
| 22 | GOLDMAN SACHS GROUP INC | 979.5K -27.7K (-2.7%) | 22.86M +3.0M (+15.2%) | 0.80% -0.026 pp | 0.00% +0.000 pp | USD17.68 +32.0% | 46 qtrs — |
| 23 | VICTORY CAPITAL MANAGEMENT INC | 884.6K +467.1K (+111.9%) | 20.65M +12.4M (+151.0%) | 0.72% +0.380 pp | 0.01% +0.007 pp | USD20.16 +15.8% | 26 qtrs — |
| 24 | RAYMOND JAMES FINANCIAL INC | 841.9K +68.6K (+8.9%) | 19.62M +4.4M (+28.8%) | 0.69% +0.054 pp | 0.01% +0.001 pp | USD21.84 +6.9% | 5 qtrs — |
| 25 | LEGAL & GENERAL GROUP PLC | 776.2K +2.1K (+0.3%) | 18.12M +2.9M (+18.8%) | 0.63% -0.001 pp | 0.00% +0.001 pp | USD18.43 +26.6% | 35 qtrs — |
| 26 | PRICE T ROWE ASSOCIATES INC /MD/ | 748.8K +5.1K (+0.7%) | 17.48M +2.8M (+19.3%) | 0.61% +0.002 pp | 0.00% +0.000 pp | USD17.62 +32.5% | 14 qtrs — |
| 27 | SYSTEMATIC FINANCIAL MANAGEMENT LP | 723.2K +37.6K (+5.5%) | 16.88M +3.4M (+25.0%) | 0.59% +0.029 pp | 0.40% +0.070 pp | USD21.07 +10.8% | 4 qtrs — |
| 28 | BANK OF NEW YORK MELLON CORP | 700.7K -3.3K (-0.5%) | 16.35M +2.5M (+17.9%) | 0.57% -0.005 pp | 0.00% +0.000 pp | USD8.99 +159.6% | 50 qtrs — |
| 29 | PRINCIPAL FINANCIAL GROUP INC | 683.7K +44.6K (+7.0%) | 15.96M +3.4M (+26.7%) | 0.56% +0.035 pp | 0.01% +0.002 pp | USD14.23 +64.0% | 35 qtrs — |
| 30 | FEDERATED HERMES, INC. | 663.8K +274.5K (+70.5%) | 15.49M +7.8M (+102.0%) | 0.54% +0.223 pp | 0.03% +0.012 pp | USD21.64 +7.9% | 27 qtrs — |
| 31 | UBS GROUP AG | 649.0K +55.4K (+9.3%) | 15.15M +3.5M (+29.5%) | 0.53% +0.043 pp | 0.00% +0.001 pp | USD19.68 +18.6% | 35 qtrs — |
| 32 | GLENMEDE TRUST CO NA | 618.2K +618.2K (+100.0%) | 14.43M +14.4M (+100.0%) | 0.50% +0.504 pp | 0.07% +0.068 pp | USD23.34 +0.0% | 1 qtrs NEW |
| 33 | SWEDBANK AB | 616.1K +— (+0.0%) | 14.38M +2.2M (+18.5%) | 0.50% -0.002 pp | 0.01% +0.002 pp | USD24.25 -3.8% | 4 qtrs — |
| 34 | METLIFE INVESTMENT MANAGEMENT, LLC | 594.1K -145.6K (-19.7%) | 13.87M -705.8K (-4.8%) | 0.48% -0.121 pp | 0.07% -0.003 pp | USD22.16 +5.3% | 33 qtrs — |
| 35 | OBERWEIS ASSET MANAGEMENT INC/ | 587.0K +58.4K (+11.1%) | 13.70M +3.3M (+31.6%) | 0.48% +0.046 pp | 0.50% +0.102 pp | USD16.74 +39.4% | 13 qtrs — |
| 36 | VOYA INVESTMENT MANAGEMENT LLC | 567.4K +121.0K (+27.1%) | 13.24M +4.5M (+50.6%) | 0.46% +0.097 pp | 0.01% +0.004 pp | USD21.14 +10.4% | 35 qtrs — |
| 37 | LSV ASSET MANAGEMENT | 539.9K -12.5K (-2.3%) | 12.60M +1.7M (+15.8%) | 0.44% -0.012 pp | 0.03% +0.003 pp | USD7.74 +201.6% | 23 qtrs — |
| 38 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 492.9K -23.8K (-4.6%) | 11.51M +1.3M (+13.0%) | 0.40% -0.021 pp | 0.04% +0.001 pp | USD18.86 +23.8% | 14 qtrs — |
| 39 | QUBE RESEARCH & TECHNOLOGIES LTD | 487.1K -334.1K (-40.7%) | 11.37M -4.8M (-29.7%) | 0.40% -0.275 pp | 0.01% -0.005 pp | USD20.25 +15.3% | 10 qtrs — |
| 40 | GABLES CAPITAL MANAGEMENT INC. | 424.6K -10.8K (-2.5%) | 9.91M +1.3M (+15.5%) | 0.35% -0.010 pp | 4.19% +0.511 pp | USD5.02 +364.9% | 32 qtrs — |
| 41 | NUVEEN, LLC | 418.5K -123.7K (-22.8%) | 9.77M -913.6K (-8.6%) | 0.34% -0.103 pp | 0.00% 0.000 pp | USD23.69 -1.5% | 4 qtrs — |
| 42 | PACER ADVISORS, INC. | 393.7K -227.1K (-36.6%) | 9.19M -3.0M (-24.9%) | 0.32% -0.187 pp | 0.02% -0.007 pp | USD16.03 +45.6% | 8 qtrs — |
| 43 | JUPITER ASSET MANAGEMENT LTD | 390.4K -10.7K (-2.7%) | 9.11M +1.2M (+15.3%) | 0.32% -0.010 pp | 0.07% +0.005 pp | USD15.05 +55.1% | 15 qtrs — |
| 44 | JW ASSET MANAGEMENT, LLC | 388.4K +— (+0.0%) | 9.07M +1.4M (+18.5%) | 0.32% -0.001 pp | 2.95% -0.721 pp | USD18.60 +25.5% | 13 qtrs — |
| 45 | ABRDN PLC | 387.9K -244.5K (-38.7%) | 9.05M -3.4M (-27.3%) | 0.32% -0.201 pp | 0.01% -0.006 pp | USD22.11 +5.6% | 5 qtrs — |
| 46 | JPMORGAN CHASE & CO | 369.8K -9.0K (-2.4%) | 8.63M +1.2M (+15.7%) | 0.30% -0.008 pp | 0.00% +0.000 pp | USD15.15 +54.1% | 36 qtrs — |
| 47 | ALLIANZ ASSET MANAGEMENT GMBH | 366.8K -431.2K (-54.0%) | 8.56M -7.2M (-45.5%) | 0.30% -0.354 pp | 0.01% -0.009 pp | USD22.24 +4.9% | 19 qtrs — |
| 48 | PRUDENTIAL FINANCIAL INC | 364.8K -38.0K (-9.4%) | 8.51M +580.0K (+7.3%) | 0.30% -0.032 pp | 0.01% +0.001 pp | USD15.49 +50.7% | 33 qtrs — |
| 49 | BARCLAYS PLC | 358.2K +109.7K (+44.2%) | 8.36M +3.4M (+69.2%) | 0.29% +0.089 pp | 0.00% +0.001 pp | USD20.46 +14.1% | 35 qtrs — |
| 50 | EVERSEPT PARTNERS, LP | 358.2K +7.4K (+2.1%) | 8.36M +1.4M (+21.0%) | 0.29% +0.005 pp | 0.42% -0.055 pp | USD19.77 +18.1% | 2 qtrs — |
| 51 | WINTON GROUP LTD | 353.5K +298.9K (+546.7%) | 8.25M +7.2M (+666.2%) | 0.29% +0.244 pp | 0.28% +0.245 pp | USD22.22 +5.0% | 8 qtrs — |
| 52 | RENAISSANCE GROUP LLC | 346.4K -9.7K (-2.7%) | 8.08M +1.1M (+15.3%) | 0.28% -0.009 pp | 0.32% +0.060 pp | USD21.43 +8.9% | 5 qtrs — |
| 53 | FMR LLC | 343.7K -18.5K (-5.1%) | 8.02M +887.1K (+12.4%) | 0.28% -0.016 pp | 0.00% +0.000 pp | USD21.65 +7.8% | 27 qtrs — |
| 54 | RHUMBLINE ADVISERS | 313.4K -16.9K (-5.1%) | 7.32M +808.1K (+12.4%) | 0.26% -0.015 pp | 0.01% +0.001 pp | USD10.94 +113.3% | 35 qtrs — |
| 55 | CITADEL ADVISORS LLC | 308.5K -89.4K (-22.5%) | 7.20M -638.8K (-8.2%) | 0.25% -0.074 pp | 0.00% 0.000 pp | USD21.12 +10.5% | 35 qtrs — |
| 56 | AQR CAPITAL MANAGEMENT LLC | 303.7K -33.4K (-9.9%) | 7.09M +447.3K (+6.7%) | 0.25% -0.028 pp | 0.00% -0.001 pp | USD13.24 +76.3% | 34 qtrs — |
| 57 | BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 300.1K -10.9K (-3.5%) | 7.00M +878.2K (+14.3%) | 0.24% -0.010 pp | 0.05% +0.005 pp | USD19.70 +18.5% | 2 qtrs — |
| 58 | GLOBEFLEX CAPITAL L P | 292.2K +1.5K (+0.5%) | 6.82M +1.1M (+19.1%) | 0.24% +0.000 pp | 1.04% +0.162 pp | USD19.04 +22.6% | 21 qtrs — |
| 59 | UBS ASSET MANAGEMENT AMERICAS INC | 279.3K +2.0K (+0.7%) | 6.52M +1.1M (+19.3%) | 0.23% +0.001 pp | 0.00% +0.000 pp | USD18.61 +25.4% | 27 qtrs — |
| 60 | JANE STREET GROUP, LLC | 266.3K +127.2K (+91.4%) | 6.21M +3.5M (+126.8%) | 0.22% +0.103 pp | 0.00% +0.001 pp | USD23.41 -0.3% | 23 qtrs — |
| 61 | SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 263.4K -72.1K (-21.5%) | 6.14M -474.7K (-7.2%) | 0.21% -0.060 pp | 0.02% -0.002 pp | USD20.58 +13.4% | 6 qtrs — |
| 62 | TREXQUANT INVESTMENT LP | 249.1K +124.8K (+100.3%) | 5.81M +3.4M (+137.4%) | 0.20% +0.101 pp | 0.05% +0.027 pp | USD21.34 +9.4% | 8 qtrs — |
| 63 | SWISS NATIONAL BANK | 229.3K +4.6K (+2.0%) | 5.35M +925.3K (+20.9%) | 0.19% +0.003 pp | 0.00% +0.001 pp | USD7.58 +207.9% | 27 qtrs — |
| 64 | AMERIPRISE FINANCIAL INC | 215.9K -26.8K (-11.0%) | 5.04M +258.0K (+5.4%) | 0.18% -0.023 pp | 0.00% +0.000 pp | USD11.57 +101.7% | 23 qtrs — |
| 65 | KNOTT DAVID M JR | 189.0K +— (+0.0%) | 4.41M +688.0K (+18.5%) | 0.15% -0.001 pp | 2.04% +0.541 pp | USD16.67 +40.0% | 9 qtrs — |
| 66 | MAN GROUP PLC | 188.8K -275.2K (-59.3%) | 4.41M -4.7M (-51.8%) | 0.15% -0.226 pp | 0.01% -0.008 pp | USD15.94 +46.4% | 25 qtrs — |
| 67 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 188.2K -60.4K (-24.3%) | 4.39M -504.3K (-10.3%) | 0.15% -0.050 pp | 0.02% -0.001 pp | USD19.70 +18.5% | 14 qtrs — |
| 68 | ADVISORS ASSET MANAGEMENT, INC. | 179.2K -13.5K (-7.0%) | 4.18M +386.6K (+10.2%) | 0.15% -0.012 pp | 0.07% +0.006 pp | USD12.74 +83.2% | 17 qtrs — |
| 69 | STIFEL FINANCIAL CORP | 177.0K +77.0K (+77.0%) | 4.13M +2.2M (+109.7%) | 0.14% +0.063 pp | 0.00% +0.002 pp | USD22.66 +3.0% | 4 qtrs — |
| 70 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 167.8K +38.7K (+30.0%) | 3.91M +1.4M (+53.9%) | 0.14% +0.031 pp | 0.01% +0.002 pp | USD21.44 +8.9% | 5 qtrs — |
| 71 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 164.2K +97.2K (+145.1%) | 3.83M +2.5M (+190.4%) | 0.13% +0.079 pp | 0.00% +0.000 pp | USD22.28 +4.8% | 33 qtrs — |
| 72 | ROYAL BANK OF CANADA | 161.7K -17.9K (-10.0%) | 3.77M +234.0K (+6.6%) | 0.13% -0.015 pp | 0.00% +0.000 pp | USD18.75 +24.5% | 39 qtrs — |
| 73 | WELLS FARGO & COMPANY/MN | 158.7K +43.6K (+37.9%) | 3.70M +1.4M (+63.4%) | 0.13% +0.035 pp | 0.00% +0.000 pp | USD21.18 +10.2% | 34 qtrs — |
| 74 | BRIDGE CITY CAPITAL, LLC | 156.7K -25.6K (-14.1%) | 3.66M +65.8K (+1.8%) | 0.13% -0.021 pp | 1.07% +0.116 pp | USD22.59 +3.3% | 4 qtrs — |
| 75 | RAFFERTY ASSET MANAGEMENT, LLC | 155.0K -2.0K (-1.3%) | 3.62M +524.8K (+17.0%) | 0.13% -0.002 pp | 0.01% +0.003 pp | USD15.53 +50.3% | 26 qtrs — |
| 76 | FRANKLIN RESOURCES INC | 153.9K -3.8K (-2.4%) | 3.59M +484.6K (+15.6%) | 0.13% -0.004 pp | 0.00% +0.000 pp | USD18.09 +29.0% | 16 qtrs — |
| 77 | DEUTSCHE BANK AG\ | 151.6K -36.1K (-19.3%) | 3.54M -160.2K (-4.3%) | 0.12% -0.030 pp | 0.00% 0.000 pp | USD16.28 +43.4% | 50 qtrs — |
| 78 | WOODLINE PARTNERS LP | 150.6K +169.0 (+0.1%) | 3.52M +551.7K (+18.6%) | 0.12% 0.000 pp | 0.01% 0.000 pp | USD15.75 +48.2% | 8 qtrs — |
| 79 | SEGALL BRYANT & HAMILL, LLC | 143.9K +63.5K (+78.9%) | 3.36M +1.8M (+111.9%) | 0.12% +0.052 pp | 0.05% +0.024 pp | USD21.95 +6.3% | 6 qtrs — |
| 80 | NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 140.4K -8.9K (-6.0%) | 3.28M +336.0K (+11.4%) | 0.11% -0.008 pp | 0.01% +0.001 pp | USD13.24 +76.3% | 14 qtrs — |
| 81 | LINDEN THOMAS ADVISORY SERVICES, LLC | 139.9K +4.3K (+3.2%) | 3.27M +594.3K (+22.2%) | 0.11% +0.003 pp | 0.33% +0.061 pp | USD20.75 +12.5% | 9 qtrs — |
| 82 | STANLEY-LAMAN GROUP, LTD. | 139.4K -3.3K (-2.3%) | 3.25M +442.5K (+15.7%) | 0.11% -0.003 pp | 0.41% +0.013 pp | USD24.25 -3.8% | 4 qtrs — |
| 83 | ASSENAGON ASSET MANAGEMENT S.A. | 138.7K -5.3K (-3.7%) | 3.24M +400.7K (+14.1%) | 0.11% -0.005 pp | 0.00% +0.001 pp | USD22.86 +2.1% | 4 qtrs — |
| 84 | BESSEMER GROUP INC | 138.6K +135.2K (+3,877.3%) | 3.24M +3.2M (+4,589.9%) | 0.11% +0.110 pp | 0.01% +0.005 pp | USD23.25 +0.4% | 11 qtrs — |
| 85 | DEKABANK DEUTSCHE GIROZENTRALE | 183.4K +— (+0.0%) | 3.06M -475.0K (-13.4%) | 0.15% -0.001 pp | 0.01% -0.001 pp | USD17.40 +34.1% | 10 qtrs — |
| 86 | QUEST PARTNERS LLC | 130.1K +66.2K (+103.5%) | 3.04M +1.8M (+141.1%) | 0.11% +0.054 pp | 0.17% +0.088 pp | USD21.95 +6.3% | 8 qtrs — |
| 87 | LOS ANGELES CAPITAL MANAGEMENT LLC | 136.6K -25.8K (-15.9%) | 2.86M -334.8K (-10.5%) | 0.11% -0.022 pp | 0.01% -0.001 pp | USD16.30 +43.2% | 31 qtrs — |
| 88 | STATE OF WISCONSIN INVESTMENT BOARD | 121.4K +49.4K (+68.6%) | 2.83M +1.4M (+99.7%) | 0.10% +0.040 pp | 0.01% +0.003 pp | USD16.52 +41.3% | 35 qtrs — |
| 89 | RUSSELL INVESTMENTS GROUP, LTD. | 121.4K -9.6K (-7.4%) | 2.83M +251.9K (+9.8%) | 0.10% -0.008 pp | 0.00% +0.000 pp | USD11.53 +102.4% | 25 qtrs — |
| 90 | MARTINGALE ASSET MANAGEMENT L P | 119.7K -715.0 (-0.6%) | 2.79M +421.6K (+17.8%) | 0.10% -0.001 pp | 0.07% +0.011 pp | USD20.11 +16.1% | 6 qtrs — |
| 91 | ALLIANCEBERNSTEIN L.P. | 118.6K -4.7K (-3.8%) | 2.77M +339.5K (+14.0%) | 0.10% -0.004 pp | 0.00% +0.000 pp | USD11.52 +102.6% | 35 qtrs — |
| 92 | CYNDEO WEALTH PARTNERS, LLC | 118.4K +— (+0.0%) | 2.76M +431.1K (+18.5%) | 0.10% 0.000 pp | 0.15% +0.019 pp | USD18.15 +28.6% | 13 qtrs — |
| 93 | STRATOS WEALTH ADVISORS, LLC | 117.7K +20.6K (+21.2%) | 2.75M +834.9K (+43.6%) | 0.10% +0.017 pp | 0.13% +0.041 pp | USD23.64 -1.3% | 4 qtrs — |
| 94 | SANCTUARY ADVISORS, LLC | 114.8K +55.6K (+94.0%) | 2.68M +1.5M (+129.9%) | 0.09% +0.045 pp | 0.01% +0.008 pp | USD21.64 +7.9% | 6 qtrs — |
| 95 | TANAKA CAPITAL MANAGEMENT INC | 114.4K +— (+0.0%) | 2.67M +417.0K (+18.5%) | 0.09% 0.000 pp | 4.87% +0.813 pp | USD19.70 +18.5% | 2 qtrs — |
| 96 | CLARK ESTATES INC/NY | 113.9K +— (+0.0%) | 2.66M +414.7K (+18.5%) | 0.09% 0.000 pp | 0.65% +0.132 pp | USD12.49 +86.9% | 10 qtrs — |
| 97 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 110.0K -100.0 (-0.1%) | 2.57M +398.4K (+18.4%) | 0.09% 0.000 pp | 0.00% +0.000 pp | USD5.31 +339.5% | 35 qtrs — |
| 98 | OPPENHEIMER & CO INC | 107.0K +15.0K (+16.3%) | 2.50M +684.9K (+37.8%) | 0.09% +0.012 pp | 0.04% +0.013 pp | USD17.97 +29.9% | 8 qtrs — |
| 99 | HUSSMAN STRATEGIC ADVISORS, INC. | 105.0K -42.0K (-28.6%) | 2.45M -445.2K (-15.4%) | 0.09% -0.035 pp | 0.59% -0.035 pp | USD15.33 +52.3% | 19 qtrs — |
| 100 | GREAT WEST LIFE ASSURANCE CO /CAN/ | 98.6K -31.4K (-24.2%) | 2.30M -242.0K (-9.5%) | 0.08% -0.026 pp | 0.00% +0.000 pp | USD14.00 +66.7% | 27 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.50
Neutral
Ratio by volume
0.80
Neutral
Buys
3
Sells
6
Shares acquired
49.9K
Shares disposed
62.8K
Cash buys
—
Cash sales
—
Net activity
-12,868
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-17 | Russo Gregg | Officer | M-Exempt | D | Restricted Stock Units | 687 | 0.00 | — | 71,786 | D | ↗ |
| 2026-01-05 | Kalb Michael Wayne | Officer | M-Exempt | D | Restricted Stock Units | 7,139 | 0.00 | — | 632,903 | D | ↗ |
| 2026-01-05 | Daly Richard J | Director / Officer | M-Exempt | D | Restricted Stock Units | 42,105 | 0.00 | — | 2,618,539 | D | ↗ |
| 2025-12-29 | Tierney David S | Director | M-Exempt | D | Restricted Stock Units | 1,334 | 0.00 | — | 178,163 | D | ↗ |
| 2025-12-29 | Sundaram Preethi | Officer | M-Exempt | A | Common Stock, par value $0.001 per share | 6,667 | 0.00 | — | 57,173 | D | ↗ |
| 2025-12-29 | Miller Steve | Officer | M-Exempt | A | Common stock, par value $0.001 per share | 14,000 | 0.00 | — | 1,093,803 | D | ↗ |
| 2025-12-29 | MCENANY PATRICK J | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 26,334 | 0.00 | — | 4,178,345 | D | ↗ |
| 2025-12-29 | Harper Molly | Director | M-Exempt | D | Restricted Stock Units | 1,334 | 0.00 | — | 127,163 | D | ↗ |
| 2025-12-29 | Elsbernd Brian | Officer | F-InKind | D | Common Stock, par value $0.001 per share | 2,623 | 0.00 | — | 242,501 | D | ↗ |
| 2025-12-29 | Del Carmen Jeffrey | Officer | F-InKind | D | Common Stock, par value $0.001 per share | 3,839 | 0.00 | — | 14,337 | D | ↗ |
| 2025-12-29 | Daly Richard J | Director / Officer | M-Exempt | A | Common Stock, par value $0.001 per share | 1,334 | 0.00 | — | 240,262 | D | ↗ |
| 2025-12-29 | DENKHAUS DONALD A | Director | M-Exempt | D | Restricted Stock Units | 1,334 | 0.00 | — | 178,163 | D | ↗ |
| 2025-12-12 | Harper Molly | Director | S-Sale | D | Common stock, par value $0.001 per share | 15,527 | 23.20 | 360.2K | 13,579 | D | ↗ |
| 2025-12-08 | Tierney David S | Director | M-Exempt | D | Restricted Stock Units | 1,413 | 0.00 | — | 179,497 | D | ↗ |
| 2025-12-08 | Thompson Tamar | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 1,413 | 0.00 | — | 3,773 | D | ↗ |
| 2025-12-08 | Sundaram Preethi | Officer | F-InKind | D | Common Stock, par value $0.001 per share | 1,669 | 0.00 | — | 50,506 | D | ↗ |
| 2025-12-08 | Miller Steve | Officer | M-Exempt | A | Common stock, par value $0.001 per share | 11,873 | 0.00 | — | 1,079,803 | D | ↗ |
| 2025-12-08 | MCENANY PATRICK J | Director | M-Exempt | D | Restricted Stock Units | 3,534 | 0.00 | — | 1,878,282 | D | ↗ |
| 2025-12-08 | Harper Molly | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 1,413 | 0.00 | — | 9,106 | D | ↗ |
| 2025-12-08 | Elsbernd Brian | Officer | F-InKind | D | Common Stock, par value $0.001 per share | 2,780 | 0.00 | — | 238,457 | D | ↗ |
| 2025-12-08 | Del Carmen Jeffrey | Officer | M-Exempt | A | Common Stock, par value $0.001 per share | 8,039 | 0.00 | — | 12,001 | D | ↗ |
| 2025-12-08 | DENKHAUS DONALD A | Director | M-Exempt | D | Restricted Stock Units | 1,413 | 0.00 | — | 179,497 | D | ↗ |
| 2025-12-01 | MCENANY PATRICK J | Director | G-Gift | D | Common stock, par value $0.001 per share | 45,000 | 0.00 | — | 4,328,477 | D | ↗ |
| 2025-11-26 | Del Carmen Jeffrey | Officer | S-Sale | D | Common Stock, par value $0.001 per share | 10,983 | 23.33 | 256.2K | 3,962 | D | ↗ |
| 2025-11-21 | Tierney David S | Director | M-Exempt | D | Restricted Stock Units | 947 | 0.00 | — | 180,910 | D | ↗ |
| 2025-11-21 | Thompson Tamar | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 947 | 0.00 | — | 2,360 | D | ↗ |
| 2025-11-21 | Sundaram Preethi | Officer | M-Exempt | D | Restricted Stock Units | 5,603 | 0.00 | — | 811,959 | D | ↗ |
| 2025-11-21 | Miller Steve | Officer | M-Exempt | D | Restricted Stock Units | 8,267 | 0.00 | — | 1,497,522 | D | ↗ |
| 2025-11-21 | MCENANY PATRICK J | Director | M-Exempt | D | Restricted Stock Units | 1,775 | 0.00 | — | 1,881,816 | D | ↗ |
| 2025-11-21 | Kalb Michael Wayne | Officer | M-Exempt | D | Restricted Stock Units | 6,894 | 0.00 | — | 640,042 | D | ↗ |
| 2025-11-21 | Harper Molly | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 947 | 0.00 | — | 7,693 | D | ↗ |
| 2025-11-21 | Elsbernd Brian | Officer | M-Exempt | D | Restricted Stock Units | 5,161 | 0.00 | — | 969,876 | D | ↗ |
| 2025-11-21 | Del Carmen Jeffrey | Officer | F-InKind | D | Common Stock, par value $0.001 per share | 1,641 | 0.00 | — | 3,962 | D | ↗ |
| 2025-11-21 | Daly Richard J | Director / Officer | M-Exempt | D | Restricted Stock Units | 20,006 | 0.00 | — | 2,661,978 | D | ↗ |
| 2025-11-21 | DENKHAUS DONALD A | Director | M-Exempt | D | Restricted Stock Units | 947 | 0.00 | — | 180,910 | D | ↗ |
| 2025-11-20 | Tierney David S | Director | A-Award | A | Restricted Stock Units | 5,468 | 0.00 | — | 181,857 | D | ↗ |
| 2025-11-20 | Thompson Tamar | Director | A-Award | A | Options to purchase common stock | 18,115 | 22.77 | 412.5K | 116,555 | D | ↗ |
| 2025-11-20 | Sundaram Preethi | Officer | A-Award | A | Restricted Stock Units | 32,257 | 0.00 | — | 817,562 | D | ↗ |
| 2025-11-20 | Russo Gregg | Officer | A-Award | A | Restricted Stock Units | 6,197 | 0.00 | — | 72,473 | D | ↗ |
| 2025-11-20 | Miller Steve | Officer | A-Award | A | Restricted Stock Units | 47,826 | 0.00 | — | 1,489,255 | D | ↗ |
| 2025-11-20 | MCENANY PATRICK J | Director | A-Award | A | Options to purchase common stock | 34,921 | 22.77 | 795.2K | 1,873,051 | D | ↗ |
| 2025-11-20 | Kalb Michael Wayne | Officer | A-Award | A | Restricted Stock Units | 39,701 | 0.00 | — | 646,936 | D | ↗ |
| 2025-11-20 | Harper Molly | Director | A-Award | A | Restricted Stock Units | 5,468 | 0.00 | — | 150,857 | D | ↗ |
| 2025-11-20 | Elsbernd Brian | Officer | A-Award | A | Options to purchase common stock | 98,652 | 22.77 | 2.25M | 945,161 | D | ↗ |
| 2025-11-20 | Del Carmen Jeffrey | Officer | A-Award | A | Options to purchase common stock | 106,873 | 22.77 | 2.43M | 1,037,881 | D | ↗ |
| 2025-11-20 | Daly Richard J | Director / Officer | A-Award | A | Options to purchase common stock | 381,948 | 22.77 | 8.70M | 2,546,695 | D | ↗ |
| 2025-11-20 | DENKHAUS DONALD A | Director | A-Award | A | Options to purchase common stock | 18,115 | 22.77 | 412.5K | 176,389 | D | ↗ |
| 2025-11-20 | Curran Daniel J. | Director | A-Award | A | Restricted Stock Units | 5,468 | 0.00 | — | 63,583 | D | ↗ |
| 2025-11-20 | Andrews William T. | Officer | A-Award | A | Restricted Stock Units | 29,776 | 0.00 | — | 268,136 | D | ↗ |
| 2025-11-12 | Elsbernd Brian | Officer | S-Sale | A | Common Stock, par value $0.001 per share | 40,000 | 22.70 | 908.0K | 231,039 | D | ↗ |
| 2025-09-08 | Elsbernd Brian | Officer | S-Sale | D | Common Stock, par value $0.001 per share | 30,000 | 20.30 | 609.0K | 271,039 | D | ↗ |
| 2025-09-04 | Elsbernd Brian | Officer | M-Exempt | D | Options to Purchase Common Stock | 30,000 | 2.24 | 67.2K | 959,084 | D | ↗ |
| 2025-09-03 | Elsbernd Brian | Officer | M-Exempt | D | Options to Purchase Common Stock | 20,000 | 2.24 | 44.8K | 989,084 | D | ↗ |
| 2025-08-27 | Tierney David S | Director | M-Exempt | D | Options to purchase common stock | 50,000 | 2.24 | 112.0K | 158,274 | D | ↗ |
| 2025-08-27 | Miller Steve | Officer | M-Exempt | D | Options to purchase common stock | 110,000 | 2.24 | 246.4K | 1,299,509 | D | ↗ |
| 2025-08-26 | Miller Steve | Officer | M-Exempt | D | Options to purchase common stock | 115,000 | 2.24 | 257.6K | 1,409,509 | D | ↗ |
| 2025-08-26 | Daly Richard J | Director / Officer | M-Exempt | D | Options to purchase common stock | 50,000 | 2.24 | 112.0K | 2,184,753 | D | ↗ |
| 2025-08-01 | Curran Daniel J. | Director | — | — | Options to purchase common stock | 40,000 | 21.12 | 844.8K | 0 | D | ↗ |
| 2025-06-11 | Sundaram Preethi | Officer | S-Sale | D | Common Stock, par value $0.001 per share | 1,600 | 26.42 | 42.3K | 41,081 | D | ↗ |
| 2025-06-10 | Sundaram Preethi | Officer | S-Sale | D | Common Stock, par value $0.001 per share | 2,324 | 26.41 | 61.4K | 42,681 | D | ↗ |
| 2025-06-09 | MCENANY PATRICK J | Director | S-Sale | D | Common Stock, par value $0.001 per share | 171,748 | 26.11 | 4.48M | 4,281,702 | D | ↗ |
| 2025-06-06 | MCENANY PATRICK J | Director | S-Sale | D | Common Stock, par value $0.001 per share | 28,252 | 25.95 | 733.0K | 4,453,450 | D | ↗ |
| 2025-06-02 | Andrews William T. | Officer | — | — | Options to purchase common stock | 124,447 | 24.90 | 3.10M | 0 | D | ↗ |
| 2025-05-30 | Daly Richard J | Director / Officer | S-Sale | A | Common stock, par value $0.001 per share | 70,000 | 24.86 | 1.74M | 199,764 | D | ↗ |
| 2025-05-14 | INGENITO GARY | Officer | S-Sale | D | Common stock, par value $0.001 per share | 44,000 | 23.63 | 1.04M | 68,873 | D | ↗ |
| 2025-05-13 | INGENITO GARY | Officer | M-Exempt | D | Options to purchase common stock | 200,000 | 3.42 | 684.0K | 590,282 | D | ↗ |
| 2025-03-06 | INGENITO GARY | Officer | S-Sale | D | Common stock, par value $0.001 per share | 180,096 | 21.67 | 3.90M | 68,873 | D | ↗ |
| 2025-03-05 | INGENITO GARY | Officer | S-Sale | D | Common stock, par value $0.001 per share | 44,904 | 22.09 | 991.9K | 68,873 | D | ↗ |
| 2025-03-03 | Elsbernd Brian | Officer | S-Sale | D | Common Stock, par value $0.001 per share | 53,255 | 22.93 | 1.22M | 188,564 | D | ↗ |
| 2025-03-03 | Del Carmen Jeffrey | Officer | S-Sale | D | Common stock, par value $0.001 per share | 30,423 | 22.89 | 696.4K | 0 | D | ↗ |
| 2025-02-14 | Tierney David S | Director | M-Exempt | D | Restricted Stock Units | 4,000 | 0.00 | — | 208,274 | D | ↗ |
| 2025-02-14 | Sundaram Preethi | Officer | M-Exempt | A | Common Stock, par value $0.001 per share | 16,667 | 0.00 | — | 50,970 | D | ↗ |
| 2025-02-14 | O'Keeffe Charles B | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 4,000 | 0.00 | — | 732,470 | D | ↗ |
| 2025-02-14 | Miller Steve | Officer | M-Exempt | D | Restricted Stock Units | 13,667 | 0.00 | — | 1,524,509 | D | ↗ |
| 2025-02-14 | INGENITO GARY | Officer | M-Exempt | A | Common Stock, par value $0.001 per share | 10,000 | 0.00 | — | 71,308 | D | ↗ |
| 2025-02-14 | Harper Molly | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 4,000 | 0.00 | — | 6,746 | D | ↗ |
| 2025-02-14 | Elsbernd Brian | Officer | M-Exempt | D | Restricted Stock Units | 9,667 | 0.00 | — | 1,071,609 | D | ↗ |
| 2025-02-14 | Del Carmen Jeffrey | Officer | M-Exempt | D | Restricted Stock Units | 10,667 | 0.00 | — | 931,008 | D | ↗ |
| 2025-02-14 | Daly Richard J | Director / Officer | M-Exempt | D | Restricted Stock Units | 4,000 | 0.00 | — | 2,234,753 | D | ↗ |
| 2025-02-14 | DENKHAUS DONALD A | Director | M-Exempt | D | Restricted Stock Units | 4,000 | 0.00 | — | 158,274 | D | ↗ |
| 2025-02-13 | Russo Gregg | Officer | — | — | Options to purchase common stock | 6,957 | 22.90 | 159.3K | 0 | D | ↗ |
| 2025-01-08 | DENKHAUS DONALD A | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 50,000 | 2.24 | 112.0K | 491,079 | D | ↗ |
| 2025-01-02 | Kalb Michael Wayne | Officer | M-Exempt | D | Restricted Stock Units | 7,138 | 0.00 | — | 475,699 | D | ↗ |
| 2025-01-02 | Daly Richard J | Director / Officer | M-Exempt | D | Restricted Stock Units | 42,105 | 0.00 | — | 2,238,753 | D | ↗ |
| 2024-12-27 | Tierney David S | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 1,333 | 0.00 | — | 351,620 | D | ↗ |
| 2024-12-27 | Sundaram Preethi | Officer | M-Exempt | A | Common Stock, par value $0.001 per share | 6,667 | 0.00 | — | 36,648 | D | ↗ |
| 2024-12-27 | O'Keeffe Charles B | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 1,333 | 0.00 | — | 728,470 | D | ↗ |
| 2024-12-27 | Miller Steve | Officer | M-Exempt | D | Restricted Stock Units | 14,000 | 0.00 | — | 1,538,176 | D | ↗ |
| 2024-12-27 | INGENITO GARY | Officer | M-Exempt | D | Restricted Stock Units | 9,000 | 0.00 | — | 1,025,282 | D | ↗ |
| 2024-12-27 | Harper Molly | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 1,333 | 0.00 | — | 2,746 | D | ↗ |
| 2024-12-27 | Elsbernd Brian | Officer | F-InKind | D | Common Stock, par value $0.001 per share | 1,941 | 0.00 | — | 181,250 | D | ↗ |
| 2024-12-27 | Del Carmen Jeffrey | Officer | M-Exempt | A | Common stock, par value $0.001 per share | 8,667 | 0.00 | — | 26,720 | D | ↗ |
| 2024-12-27 | Daly Richard J | Director / Officer | F-InKind | D | Common Stock, par value $0.001 per share | 324 | 0.00 | — | 235,833 | D | ↗ |
| 2024-12-27 | DENKHAUS DONALD A | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 1,333 | 0.00 | — | 441,079 | D | ↗ |
| 2024-12-13 | Miller Steve | Officer | M-Exempt | D | Options to purchase common stock | 235,000 | 4.01 | 942.4K | 1,552,176 | D | ↗ |
| 2024-12-10 | O'Keeffe Charles B | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 40,000 | 4.01 | 160.4K | 727,137 | D | ↗ |
| 2024-12-10 | Miller Steve | Officer | M-Exempt | D | Options to purchase common stock | 50,000 | 4.01 | 200.5K | 1,787,176 | D | ↗ |
| 2024-12-09 | Tierney David S | Director | M-Exempt | D | Restricted Stock Units | 1,413 | 0.00 | — | 213,607 | D | ↗ |
| 2024-12-09 | Thompson Tamar | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 1,413 | 0.00 | — | 1,413 | D | ↗ |
| 2024-12-09 | Sundaram Preethi | Officer | M-Exempt | D | Restricted Stock Units | 6,855 | 0.00 | — | 701,766 | D | ↗ |
| 2024-12-09 | O'Keeffe Charles B | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 1,413 | 0.00 | — | 687,137 | D | ↗ |
| 2024-12-09 | Miller Steve | Officer | M-Exempt | D | Restricted Stock Units | 11,872 | 0.00 | — | 1,837,176 | D | ↗ |
| 2024-12-09 | MCENANY PATRICK J | Director | M-Exempt | D | Restricted Stock Units | 3,533 | 0.00 | — | 1,838,130 | D | ↗ |
| 2024-12-09 | INGENITO GARY | Officer | M-Exempt | A | Common Stock, par value $0.001 per share | 7,349 | 0.00 | — | 58,740 | D | ↗ |
| 2024-12-09 | Harper Molly | Director | M-Exempt | D | Restricted Stock Units | 1,413 | 0.00 | — | 132,607 | D | ↗ |
| 2024-12-09 | Elsbernd Brian | Officer | M-Exempt | D | Restricted Stock Units | 7,067 | 0.00 | — | 1,087,943 | D | ↗ |
| 2024-12-09 | Del Carmen Jeffrey | Officer | M-Exempt | A | Common stock, par value $0.001 per share | 8,039 | 0.00 | — | 20,408 | D | ↗ |
| 2024-12-09 | DENKHAUS DONALD A | Director | M-Exempt | D | Restricted Stock Units | 1,413 | 0.00 | — | 213,607 | D | ↗ |
| 2024-11-27 | INGENITO GARY | Officer | M-Exempt | D | Options to purchase common stock | 12,000 | 4.01 | 48.1K | 1,041,631 | D | ↗ |
| 2024-11-27 | Harper Molly | Director | M-Exempt | D | Options to purchase common stock | 17,500 | 5.78 | 101.2K | 134,020 | D | ↗ |
| 2024-11-26 | Elsbernd Brian | Officer | S-Sale | D | Common Stock, par value $0.001 per share | 9,300 | 21.65 | 201.3K | 165,377 | D | ↗ |
| 2024-11-21 | Tierney David S | Director | A-Award | A | Restricted Stock Units | 2,841 | 0.00 | — | 215,020 | D | ↗ |
| 2024-11-21 | Thompson Tamar | Director | A-Award | A | Options to purchase common stock | 23,248 | 21.12 | 491.0K | 97,012 | D | ↗ |
| 2024-11-21 | Sundaram Preethi | Officer | A-Award | A | Options to purchase common stock | 16,809 | 0.00 | — | 708,621 | D | ↗ |
| 2024-11-21 | O'Keeffe Charles B | Director | A-Award | A | Restricted stock units | 2,841 | 0.00 | — | 255,020 | D | ↗ |
| 2024-11-21 | Miller Steve | Officer | A-Award | A | Restricted Stock Units | 24,801 | 0.00 | — | 1,849,048 | D | ↗ |
| 2024-11-21 | MCENANY PATRICK J | Director | A-Award | A | Options to purchase common stock | 43,591 | 21.12 | 920.6K | 1,836,336 | D | ↗ |
| 2024-11-21 | Kalb Michael Wayne | Officer | A-Award | A | Options to purchase common stock | 169,248 | 21.12 | 3.57M | 462,155 | D | ↗ |
| 2024-11-21 | INGENITO GARY | Officer | A-Award | A | Options to purchase common stock | 125,696 | 21.12 | 2.65M | 1,038,271 | D | ↗ |
| 2024-11-21 | Harper Molly | Director | A-Award | A | Options to purchase common stock | 23,248 | 21.12 | 491.0K | 148,679 | D | ↗ |
| 2024-11-21 | Elsbernd Brian | Officer | A-Award | A | Options to purchase common stock | 126,704 | 21.12 | 2.68M | 1,139,527 | D | ↗ |
| 2024-11-21 | Del Carmen Jeffrey | Officer | A-Award | D | Options to purchase common stock | 137,553 | 21.12 | 2.91M | 941,572 | D | ↗ |
| 2024-11-21 | Daly Richard J | Director / Officer | A-Award | A | Options to purchase common stock | 491,160 | 21.12 | 10.37M | 2,222,172 | D | ↗ |
| 2024-11-21 | DENKHAUS DONALD A | Director | A-Award | A | Restricted Stock Units | 2,841 | 0.00 | — | 215,020 | D | ↗ |
| 2024-11-20 | MCENANY PATRICK J | Director | M-Exempt | D | Options to purchase common stock | 72,500 | 3.54 | 256.7K | 1,792,745 | D | ↗ |
| 2024-11-20 | INGENITO GARY | Officer | M-Exempt | D | Options to purchase common stock | 38,000 | 4.01 | 152.4K | 912,575 | D | ↗ |
| 2024-11-19 | MCENANY PATRICK J | Director | M-Exempt | D | Options to purchase common stock | 98,345 | 3.54 | 348.1K | 1,865,245 | D | ↗ |
| 2024-11-14 | MCENANY PATRICK J | Director | M-Exempt | D | Options to purchase common stock | 44,655 | 3.54 | 158.1K | 1,963,590 | D | ↗ |
| 2024-11-13 | MCENANY PATRICK J | Director | S-Sale | D | Common stock, par value $0.001 per share | 92,500 | 22.98 | 2.13M | 4,478,169 | D | ↗ |
| 2024-11-12 | MCENANY PATRICK J | Director | M-Exempt | A | Common stock, par value $0.001 per share | 192,000 | 3.54 | 679.7K | 4,670,169 | D | ↗ |
| 2024-11-11 | MCENANY PATRICK J | Director | M-Exempt | A | Common stock, par value $0.001 per share | 230,000 | 4.01 | 922.3K | 4,708,169 | D | ↗ |
| 2024-08-22 | Tierney David S | Director | M-Exempt | A | Options to purchase common stock | 15,000 | 4.01 | 60.2K | 188,931 | — | ↗ |
| 2024-08-22 | MCENANY PATRICK J | Director | G-Gift | D | Common Stock, par value $0.001 per share | 5,100 | 0.00 | — | 4,478,169 | — | ↗ |
| 2024-08-21 | Tierney David S | Director | M-Exempt | A | Common stock, par value $0.001 per share | 15,000 | 4.01 | 60.2K | 363,874 | — | ↗ |
| 2024-08-20 | Miller Steve | Officer | S-Sale | D | Common stock, par value $0.001 per share | 50,000 | 20.26 | 1.01M | 775,124 | — | ↗ |
| 2024-08-15 | MCENANY PATRICK J | Director | G-Gift | D | Common Stock, par value $0.001 per share | 45,000 | 0.00 | — | 4,483,269 | — | ↗ |
| 2024-08-09 | INGENITO GARY | Officer | S-Sale | D | Common stock, par value $0.001 per share | 100,000 | 18.04 | 1.80M | 51,391 | — | ↗ |
| 2024-08-09 | Del Carmen Jeffrey | Officer | S-Sale | D | Common stock, par value $0.001 per share | 30,000 | 18.42 | 552.6K | 12,369 | — | ↗ |
| 2024-06-07 | Del Carmen Jeffrey | Officer | S-Sale | D | Common stock, par value $0.001 per share | 7,541 | 16.07 | 121.2K | 18,427 | — | ↗ |
| 2024-06-05 | INGENITO GARY | Officer | M-Exempt | D | Options to purchase common stock | 80,000 | 4.01 | 320.8K | 1,050,575 | — | ↗ |
| 2024-06-04 | Daly Richard J | Director / Officer | M-Exempt | D | Options to purchase common stock | 40,000 | 4.01 | 160.4K | 1,731,012 | — | ↗ |
| 2024-06-03 | Harper Molly | Director | S-Sale | D | Common Stock, par value $0.001 per share | 5,333 | 16.30 | 86.9K | 0 | — | ↗ |
| 2024-04-08 | Tierney David S | Director | M-Exempt | A | Common stock, par value $0.001 per share | 25,000 | 4.01 | 100.3K | 373,874 | — | ↗ |
| 2024-03-27 | Elsbernd Brian | Officer | S-Sale | D | Common stock, par value $0.001 per share | 25,000 | 16.44 | 411.0K | 124,433 | — | ↗ |
| 2024-02-15 | Tierney David S | Director | M-Exempt | A | Common Stock, Par Value $0.001 per share | 4,000 | 0.00 | — | 348,874 | — | ↗ |
| 2024-02-15 | Sundaram Preethi | Officer | F-InKind | D | Common Stock, par value $0.001 per share | 6,025 | 0.00 | — | 25,541 | — | ↗ |
| 2024-02-15 | O'Keeffe Charles B | Director | M-Exempt | D | Restricted Stock Units | 4,000 | 0.00 | — | 228,931 | — | ↗ |
| 2024-02-15 | Miller Steve | Officer | M-Exempt | D | Restricted Stock Units | 13,667 | 0.00 | — | 1,621,289 | — | ↗ |
| 2024-02-15 | INGENITO GARY | Officer | M-Exempt | D | Restricted Stock Units | 10,000 | 0.00 | — | 1,130,575 | — | ↗ |
| 2024-02-15 | Harper Molly | Director | M-Exempt | D | Restricted Stock Units | 4,000 | 0.00 | — | 125,431 | — | ↗ |
| 2024-02-15 | Elsbernd Brian | Officer | M-Exempt | D | Restricted Stock Units | 9,667 | 0.00 | — | 1,012,823 | — | ↗ |
| 2024-02-15 | Del Carmen Jeffrey | Officer | M-Exempt | D | Restricted Stock Units | 10,667 | 0.00 | — | 834,019 | — | ↗ |
| 2024-02-15 | Daly Richard J | Director / Officer | F-InKind | D | Common stock, par value $0.001 per share | 1,186 | 0.00 | — | 212,147 | — | ↗ |
| 2024-02-15 | DENKHAUS DONALD A | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 4,000 | 0.00 | — | 438,333 | — | ↗ |
| 2024-02-05 | DENKHAUS DONALD A | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 40,000 | 4.01 | 160.4K | 434,333 | — | ↗ |
| 2024-01-30 | MCENANY PATRICK J | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 116,667 | 0.00 | — | 4,528,256 | — | ↗ |
| 2024-01-02 | Tierney David S | Director | M-Exempt | A | Common Stock, Par Value $0.001 per share | 10,000 | 1.13 | 11.3K | 344,874 | — | ↗ |
| 2024-01-02 | O'Keeffe Charles B | Director | M-Exempt | D | Options to purchase common stock | 60,000 | 1.13 | 67.8K | 232,931 | — | ↗ |
| 2024-01-02 | MCENANY PATRICK J | Director | M-Exempt | A | Common stock, par value $0.001 per share | 250,000 | 1.13 | 282.5K | 4,385,256 | — | ↗ |
| 2024-01-01 | Kalb Michael Wayne | Officer | — | D | Options to purchase common stock | 257,214 | 16.81 | 4.32M | 0 | — | ↗ |
| 2024-01-01 | Daly Richard J | Director / Officer | A-Award | A | Restricted Stock Units | 210,526 | 0.00 | — | 1,775,012 | — | ↗ |
| 2023-12-27 | Tierney David S | Director | M-Exempt | A | Common Stock, Par Value $0.001 per share | 1,333 | 0.00 | — | 334,874 | — | ↗ |
| 2023-12-27 | Sundaram Preethi | Officer | M-Exempt | D | Restricted Stock Units | 6,666 | 0.00 | — | 570,926 | — | ↗ |
| 2023-12-27 | O'Keeffe Charles B | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 1,333 | 0.00 | — | 621,724 | — | ↗ |
| 2023-12-27 | Miller Steve | Officer | M-Exempt | D | Restricted Stock Units | 14,000 | 0.00 | — | 1,634,956 | — | ↗ |
| 2023-12-27 | MCENANY PATRICK J | Director / Officer | F-InKind | D | Common Stock, par value $0.001 per share | 10,362 | 0.00 | — | 4,135,256 | — | ↗ |
| 2023-12-27 | INGENITO GARY | Officer | M-Exempt | D | Restricted Stock Units | 9,000 | 0.00 | — | 1,140,575 | — | ↗ |
| 2023-12-27 | Harper Molly | Director | M-Exempt | D | Restricted Stock Units | 1,333 | 0.00 | — | 129,431 | — | ↗ |
| 2023-12-27 | GRANDE ALICIA | Officer | F-InKind | D | Common Stock, par value $0.001 per share | 3,410 | 0.00 | — | 55,813 | — | ↗ |
| 2023-12-27 | Elsbernd Brian | Officer | M-Exempt | D | Restricted Stock Units | 6,666 | 0.00 | — | 1,022,490 | — | ↗ |
| 2023-12-27 | Del Carmen Jeffrey | Officer | F-InKind | D | Common stock, par value $0.001 per share | 3,839 | 0.00 | — | 18,426 | — | ↗ |
| 2023-12-27 | Daly Richard J | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 1,333 | 0.00 | — | 209,333 | — | ↗ |
| 2023-12-27 | DENKHAUS DONALD A | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 1,333 | 0.00 | — | 394,333 | — | ↗ |
| 2023-12-15 | Harper Molly | Director | M-Exempt | D | Options to purchase common stock | 10,000 | 5.78 | 57.8K | 130,764 | — | ↗ |
| 2023-12-12 | Tierney David S | Director | M-Exempt | A | Common stock, par value $0.001 per share | 50,000 | 1.13 | 56.5K | 383,541 | — | ↗ |
| 2023-12-11 | Miller Steve | Officer | M-Exempt | A | Common stock, par value $0.001 per share | 150,000 | 1.13 | 169.5K | 797,457 | — | ↗ |
| 2023-12-11 | GRANDE ALICIA | Officer | M-Exempt | D | Options to purchase common stock | 60,000 | 1.13 | 67.8K | 1,195,834 | — | ↗ |
| 2023-12-08 | Tierney David S | Director | A-Award | A | Restricted Stock Units | 4,240 | 0.00 | — | 294,264 | — | ↗ |
| 2023-12-08 | Thompson Tamar | Director | A-Award | A | Options to purchase common stock | 29,524 | 14.15 | 417.8K | 69,524 | — | ↗ |
| 2023-12-08 | Sundaram Preethi | Officer | A-Award | A | Options to purchase common stock | 143,193 | 14.15 | 2.03M | 557,027 | — | ↗ |
| 2023-12-08 | O'Keeffe Charles B | Director | A-Award | A | Options to purchase common stock | 29,524 | 14.15 | 417.8K | 290,024 | — | ↗ |
| 2023-12-08 | Miller Steve | Officer | A-Award | A | Options to purchase common stock | 248,004 | 14.15 | 3.51M | 1,763,338 | — | ↗ |
| 2023-12-08 | MCENANY PATRICK J | Director / Officer | A-Award | A | Options to purchase common stock | 73,810 | 14.15 | 1.04M | 3,001,477 | — | ↗ |
| 2023-12-08 | INGENITO GARY | Officer | A-Award | A | Options to purchase common stock | 153,526 | 14.15 | 2.17M | 1,127,526 | — | ↗ |
| 2023-12-08 | Harper Molly | Director | A-Award | A | Options to purchase common stock | 29,524 | 14.15 | 417.8K | 136,524 | — | ↗ |
| 2023-12-08 | GRANDE ALICIA | Officer | S-Sale | D | Common Stock, par value $0.001 per share | 20,000 | 14.25 | 285.0K | 70,557 | — | ↗ |
| 2023-12-08 | Elsbernd Brian | Officer | A-Award | A | Options to purchase common stock | 147,621 | 14.15 | 2.09M | 1,007,955 | — | ↗ |
| 2023-12-08 | Del Carmen Jeffrey | Officer | A-Award | A | Options to purchase common stock | 167,918 | 14.15 | 2.38M | 829,235 | — | ↗ |
| 2023-12-08 | DENKHAUS DONALD A | Director | A-Award | A | Options to purchase common stock | 29,524 | 14.15 | 417.8K | 230,024 | — | ↗ |
| 2023-12-07 | Daly Richard J | Director | M-Exempt | A | Common Stock, par value $0.001 per share | 60,000 | 1.13 | 67.8K | 208,000 | — | ↗ |
| 2023-12-06 | INGENITO GARY | Officer | M-Exempt | A | Common stock, par value $0.001 per share | 50,000 | 1.13 | 56.5K | 88,367 | — | ↗ |
| 2023-12-05 | Miller Steve | Officer | S-Sale | D | Common stock, par value $0.001 per share | 40,000 | 14.24 | 569.6K | 647,457 | — | ↗ |
| 2023-08-03 | DENKHAUS DONALD A | Director | M-Exempt | A | Common stock, par value $0.001 per share | 60,000 | 1.13 | 67.8K | 393,000 | — | ↗ |
| 2023-06-27 | Del Carmen Jeffrey | Officer | M-Exempt | D | Restricted Stock Units | 10,000 | 0.00 | — | 661,317 | — | ↗ |
| 2023-05-25 | Thompson Tamar | Director | — | D | Options to purchase Common Stock | 40,000 | 11.60 | 464.0K | 0 | — | ↗ |
| 2023-05-16 | MCENANY PATRICK J | Director / Officer | M-Exempt | A | Common stock, par value $0.001 per share | 173,849 | 0.79 | 137.3K | 4,119,285 | — | ↗ |
| 2023-05-15 | MCENANY PATRICK J | Director / Officer | M-Exempt | A | Common stock, par value $0.001 per share | 26,151 | 0.79 | 20.7K | 3,971,587 | — | ↗ |
| 2023-05-12 | Daly Richard J | Director | M-Exempt | D | Options to purchase common stock | 50,000 | 0.79 | 39.5K | 260,500 | — | ↗ |
| 2023-05-11 | Tierney David S | Director | M-Exempt | D | Options to purchase common stock | 20,000 | 0.79 | 15.8K | 260,500 | — | ↗ |
| 2023-05-11 | Miller Steve | Officer | M-Exempt | D | Options to purchase common stock | 100,000 | 0.79 | 79.0K | 1,515,334 | — | ↗ |
Executive team
Top executives
EBIT / Employee
1.57M
Shares Outstanding
122.35M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Richard J. Daly, President and CEO | 750.0K | 590.6K | — | 5.07M | — | 95.1K | 7.77M | 65.23% | ↗ |
| 2 | 2024 | Michael W. Kalb, EVP and CFO | 525.0K | 350.6K | — | 4.15M | — | 121.2K | 6.18M | 67.10% | ↗ |
| 3 | 2024 | Steven R. Miller, COO and CSO | 560.0K | 352.8K | — | 2.10M | — | 13.8K | 3.55M | 59.10% | ↗ |
| 4 | 2024 | Jeffrey Del Carmen, CCO | 525.0K | 275.6K | — | 1.42M | — | 62.4K | 2.64M | 53.83% | ↗ |
| 5 | 2024 | Preethi Sundaram, Chief Strategy Officer | 485.0K | 254.6K | — | 1.42M | — | 13.8K | 2.53M | 56.16% | ↗ |
| 6 | 2023 | Steven R. Miller, COO and CSO | 525.0K | 346.5K | — | 2.02M | — | 13.2K | 3.40M | 59.21% | ↗ |
| 7 | 2023 | Jeffrey Del Carmen, CCO | 475.0K | 256.5K | — | 1.36M | — | 68.3K | 2.51M | 54.47% | ↗ |
| 8 | 2023 | Gary Ingenito, Chief Medical and Regulatory Officer | 500.0K | 270.0K | — | 1.25M | — | 41.4K | 2.37M | 52.63% | ↗ |
| 9 | 2023 | Patrick J. McEnany Former President and CEO | 735.0K | 661.5K | — | 600.0K | — | — | 2.15M | 27.95% | ↗ |
| 10 | 2023 | Preethi Sundaram, Chief Strategy Officer | 440.0K | 237.6K | — | 1.16M | — | 13.2K | 2.15M | 54.25% | ↗ |
| 11 | 2023 | Alicia Grande, Former CFO | 475.0K | 256.5K | — | — | — | 13.2K | 744.7K | 0.00% | ↗ |
| 12 | 2022 | Patrick J. McEnany Chairman, President and CEO | 691.9K | 504.0K | — | 2.93M | — | — | 6.92M | 42.36% | ↗ |
| 13 | 2022 | Patrick J. McEnany Former President and CEO | 691.9K | 504.0K | — | 2.93M | — | — | 6.92M | 42.36% | ↗ |
| 14 | 2022 | Steven R. Miller, COO and CSO | 496.8K | 300.0K | — | 1.57M | — | 12.2K | 3.47M | 45.30% | ↗ |
| 15 | 2022 | Gary Ingenito, Chief Medical and Regulatory Officer | 484.4K | 232.8K | — | 1.00M | — | 34.6K | 2.48M | 40.37% | ↗ |
| 16 | 2022 | Jeffrey Del Carmen, CCO | 449.0K | 211.2K | — | 948.8K | — | 51.5K | 2.39M | 39.76% | ↗ |
| 17 | 2022 | Alicia Grande, CFO | 442.1K | 213.6K | — | 948.8K | — | 12.2K | 2.35M | 40.31% | ↗ |
| 18 | 2022 | Alicia Grande, Former CFO | 442.1K | 213.6K | — | 948.8K | — | 12.2K | 2.35M | 40.31% | ↗ |
| 19 | 2022 | Preethi Sundaram, Chief Strategy Officer | 415.7K | 226.6K | — | 733.2K | — | 12.2K | 2.14M | 34.29% | ↗ |
| 20 | 2021 | Patrick J. McEnany Chairman, President and CEO | 632.3K | 415.8K | — | 1.04M | — | — | 2.09M | 49.84% | ↗ |
| 21 | 2021 | Patrick J. McEnany Former President and CEO | 632.3K | 415.8K | — | 1.04M | — | — | 2.09M | 49.84% | ↗ |
| 22 | 2021 | Preethi Sundaram, Chief Strategy Officer | 194.4K | 110.8K | — | 1.19M | — | 454.00 | 1.50M | 79.58% | ↗ |
| 23 | 2021 | Steven R. Miller, COO and CSO | 474.2K | 259.9K | — | 713.5K | — | 11.6K | 1.46M | 48.90% | ↗ |
| 24 | 2021 | Alicia Grande, Former CFO | 421.5K | 184.8K | — | 646.0K | — | 11.6K | 1.26M | 51.11% | ↗ |
| 25 | 2021 | Alicia Grande, CFO | 421.5K | 184.8K | — | 646.0K | — | 11.6K | 1.26M | 51.11% | ↗ |
| 26 | 2021 | Gary Ingenito, Chief Medical and Regulatory Officer | 469.8K | 205.6K | — | 520.7K | — | 31.5K | 1.23M | 42.42% | ↗ |
| 27 | 2021 | Jeffrey Del Carmen, CCO | 400.7K | 176.0K | — | 520.7K | — | 48.3K | 1.15M | 45.44% | ↗ |
| 28 | 2020 | Patrick J. McEnany Chairman, President and CEO | 604.2K | 324.0K | — | 834.1K | — | — | 1.76M | 47.33% | ↗ |
| 29 | 2020 | Jeffrey Del Carmen, CCO | 339.2K | 119.5K | — | 957.0K | — | 49.2K | 1.61M | 59.59% | ↗ |
| 30 | 2020 | Steven R. Miller, COO and CSO | 453.3K | 202.5K | — | 573.4K | — | 11.4K | 1.24M | 46.22% | ↗ |
| 31 | 2020 | Alicia Grande, CFO | 402.9K | 144.0K | — | 521.3K | — | 11.4K | 1.08M | 48.29% | ↗ |
| 32 | 2020 | Gary Ingenito, Chief Medical and Regulatory Officer | 448.7K | 160.2K | — | 417.0K | — | 30.4K | 1.06M | 39.48% | ↗ |
| 33 | 2019 | Patrick J. McEnany Chairman, President and CEO | 548.3K | 360.4K | — | 2.03M | — | — | 3.37M | 60.32% | ↗ |
| 34 | 2019 | Steven R. Miller, COO and CSO | 427.4K | 204.7K | — | 494.7K | — | 11.2K | 1.42M | 34.93% | ↗ |
| 35 | 2019 | Gary Ingenito, CM&RO | 417.8K | 199.7K | — | 362.8K | — | 29.3K | 1.21M | 29.89% | ↗ |
| 36 | 2019 | Gary Ingenito, Chief Medical and Regulatory Officer | 417.8K | 199.7K | — | 362.8K | — | 29.3K | 1.21M | 29.89% | ↗ |
| 37 | 2019 | Alicia Grande, CFO | 376.5K | 180.0K | — | 362.8K | — | 11.2K | 1.13M | 31.97% | ↗ |
| 38 | 2018 | Patrick J. McEnany Chairman, President and CEO | 524.2K | 332.1K | — | 2.61M | — | — | 3.46M | 75.26% | ↗ |
| 39 | 2018 | Gary Ingenito, CMO and Head of Regulatory Affairs | 399.4K | 194.8K | — | 1.05M | — | 26.2K | 1.67M | 62.78% | ↗ |
| 40 | 2018 | Gary Ingenito, Chief Medical and Regulatory Officer | 399.4K | 194.8K | — | 1.05M | — | 26.2K | 1.67M | 62.78% | ↗ |
| 41 | 2018 | Gary Ingenito, CM&RO | 399.4K | 194.8K | — | 1.05M | — | 26.2K | 1.67M | 62.78% | ↗ |
| 42 | 2018 | Steven R. Miller, COO and CSO | 409.3K | 188.6K | — | 1.05M | — | 11.0K | 1.66M | 63.21% | ↗ |
| 43 | 2018 | Alicia Grande, CFO | 354.1K | 163.3K | — | 1.05M | — | 11.0K | 1.57M | 66.44% | ↗ |
| 44 | 2017 | Patrick J. McEnany Chairman, President and CEO | 485.0K | 206.2K | — | 209.3K | — | — | 900.5K | 23.24% | ↗ |
| 45 | 2017 | Steven R. Miller, COO and CSO | 374.7K | 95.6K | — | 125.4K | — | 10.8K | 606.5K | 20.68% | ↗ |
| 46 | 2017 | Gary Ingenito, CMO and Head of Regulatory Affairs | 367.2K | 93.7K | — | 125.4K | — | 8.8K | 595.1K | 21.08% | ↗ |
| 47 | 2017 | Alicia Grande, Vice President, Treasurer and CFO | 308.8K | 78.8K | — | 125.4K | — | 10.8K | 523.9K | 23.94% | ↗ |
| 48 | 2017 | Brian Elsbernd, Vice President, Legal and Compliance | 283.1K | 28.3K | — | 41.9K | — | — | 353.3K | 11.85% | ↗ |
| 49 | 2016 | Patrick J. McEnany Chairman, President and CEO | 473.0K | 23.6K | — | 111.2K | — | — | 607.7K | 18.29% | ↗ |
| 50 | 2016 | Steven R. Miller, COO and CSO | 365.4K | 18.2K | — | 55.6K | — | 10.6K | 449.8K | 12.36% | ↗ |
| 51 | 2016 | Gary Ingenito, CMO and Head of Regulatory Affairs | 358.0K | 17.8K | — | 55.6K | — | — | 431.4K | 12.88% | ↗ |
| 52 | 2016 | Alicia Grande, Vice President, Treasurer and CFO | 301.0K | 15.0K | — | 55.6K | — | 10.6K | 382.2K | 14.54% | ↗ |
| 53 | 2016 | Brian Elsbernd, Vice President, Legal and Compliance | 242.0K | 13.8K | — | 108.6K | — | 17.0K | 381.4K | 28.48% | ↗ |
| 54 | 2016 | Paul Merrigan, former Chief Commercial Officer | 320.0K | — | — | 8.8K | — | 1.0K | 329.8K | 2.67% | ↗ |
| 55 | 2015 | Patrick J. McEnany Chairman, President and CEO | 453.0K | 169.9K | — | 532.8K | — | — | 1.16M | 46.10% | ↗ |
| 56 | 2015 | Gary Ingenito, Chief Medical Officer | 166.2K | 75.4K | — | 726.6K | — | — | 968.2K | 75.05% | ↗ |
| 57 | 2015 | Gary Ingenito, CMO and Head of Regulatory Affairs | 166.2K | 75.4K | — | 726.6K | — | — | 968.2K | 75.05% | ↗ |
| 58 | 2015 | Paul J. Merrigan, Chief Commercial Officer | 98.8K | 24.4K | — | 677.8K | — | — | 800.9K | 84.63% | ↗ |
| 59 | 2015 | Paul Merrigan, former Chief Commercial Officer | 98.8K | 24.4K | — | 677.8K | — | — | 800.9K | 84.63% | ↗ |
| 60 | 2015 | Steven R. Miller, Chief Operating Officer and Chief Scientific Officer | 350.0K | 78.8K | — | 274.4K | — | 10.6K | 713.8K | 38.44% | ↗ |
| 61 | 2015 | Steven R. Miller, COO and CSO | 350.0K | 78.8K | — | 274.4K | — | 10.6K | 713.8K | 38.44% | ↗ |
| 62 | 2015 | Alicia Grande, Vice President, Treasurer and CFO | 288.0K | 64.8K | — | 274.4K | — | 10.6K | 637.8K | 43.02% | ↗ |
| 63 | 2014 | Patrick J. McEnany Chairman, President and CEO | 425.0K | 85.0K | — | — | — | — | 1.47M | 0.00% | ↗ |
| 64 | 2014 | Patrick J. McEnany Chairman, President and CEO | 425.0K | 85.0K | — | 734.5K | — | — | 1.47M | 49.93% | ↗ |
| 65 | 2014 | Steven R. Miller, Chief Operating Officer and Chief Scientific Officer | 300.0K | 100.0K | — | 452.9K | — | 10.4K | 863.3K | 52.46% | ↗ |
| 66 | 2014 | Steven R. Miller, COO and CSO | 300.0K | 100.0K | — | 452.9K | — | 10.4K | 863.3K | 52.46% | ↗ |
| 67 | 2014 | Steven R. Miller, Chief Operating Officer and Chief Scientific Officer | 300.0K | 100.0K | — | — | — | 10.4K | 863.3K | 0.00% | ↗ |
| 68 | 2014 | Alicia Grande Vice President, Treasurer and CFO | 240.0K | 48.0K | — | — | — | 9.9K | 714.1K | 0.00% | ↗ |
| 69 | 2014 | Alicia Grande, Vice President, Treasurer and CFO | 240.0K | 48.0K | — | 416.2K | — | 9.9K | 714.1K | 58.28% | ↗ |
| 70 | 2013 | Patrick J. McEnany Chairman, President and CEO | 406.2K | 20.3K | — | — | — | — | 426.5K | 0.00% | ↗ |
| 71 | 2013 | Patrick J. McEnany Chairman, President and CEO | 406.2K | 20.3K | — | — | — | — | 426.5K | 0.00% | ↗ |
| 72 | 2013 | Steven R. Miller, Chief Operating Officer and Chief Scientific Officer | 275.6K | 33.8K | — | — | — | 9.4K | 318.8K | 0.00% | ↗ |
| 73 | 2013 | Steven R. Miller, Chief Operating Officer and Chief Scientific Officer | 275.6K | 33.8K | — | — | — | 9.4K | 318.8K | 0.00% | ↗ |
| 74 | 2013 | Steven R. Miller, Ph.D. Chief Operating Officer and Chief Scientific Officer | 275.6K | 33.8K | — | — | — | 9.4K | 318.8K | 0.00% | ↗ |
| 75 | 2013 | Alicia Grande, Vice President, Treasurer and CFO | 220.0K | 11.0K | — | — | — | 8.8K | 239.8K | 0.00% | ↗ |
| 76 | 2013 | Alicia Grande Vice President, Treasurer and CFO | 220.0K | 11.0K | — | — | — | 8.8K | 239.8K | 0.00% | ↗ |
| 77 | 2012 | Patrick J. McEnany Chairman, President and CEO | 386.9K | 7.7K | — | — | — | — | 461.0K | 0.00% | ↗ |
| 78 | 2012 | Steven R. Miller, Chief Operating Officer and Chief Scientific Officer | 262.5K | 17.8K | — | — | — | 10.5K | 357.2K | 0.00% | ↗ |
| 79 | 2012 | Steven R. Miller, Ph.D. Chief Operating Officer and Chief Scientific Officer | 262.5K | 17.8K | — | — | — | 10.5K | 357.2K | 0.00% | ↗ |
| 80 | 2012 | Steven R. Miller Chief Operating Officer and Chief Scientific Officer | 262.5K | 17.8K | — | — | — | 10.5K | 357.2K | 0.00% | ↗ |
| 81 | 2012 | Alicia Grande Vice President, Treasurer and CFO | 200.0K | 4.0K | — | — | — | 8.0K | 278.4K | 0.00% | ↗ |
| 82 | 2012 | Jack Weinstein | — | — | — | — | — | — | — | — | ↗ |
| 83 | 2011 | Patrick J. McEnany Chairman, President and CEO | 368.4K | 11.1K | — | — | — | — | 458.8K | 0.00% | ↗ |
| 84 | 2011 | Patrick J. McEnany Chairman, President and CEO | 368.4K | 11.1K | — | — | — | — | 458.8K | 0.00% | ↗ |
| 85 | 2011 | Steven R. Miller, Ph.D. Chief Operating Officer and Chief Scientific Officer | 250.0K | 27.5K | — | — | — | 10.0K | 358.9K | 0.00% | ↗ |
| 86 | 2011 | Steven R. Miller, Chief Operating Officer and Chief Scientific Officer | 250.0K | 27.5K | — | — | — | 10.0K | 358.9K | 0.00% | ↗ |
| 87 | 2011 | Steven R. Miller Chief Operating Officer and Chief Scientific Officer | 250.0K | 27.5K | — | — | — | 10.0K | 358.9K | 0.00% | ↗ |
| 88 | 2011 | Jack Weinstein CFO, Treasurer and VP, Business Development | 233.9K | 7.0K | — | — | — | 9.0K | 249.9K | 0.00% | ↗ |
| 89 | 2011 | Alicia Grande Vice President, Treasurer and CFO | 159.7K | 4.8K | — | — | — | 6.4K | 242.2K | 0.00% | ↗ |
| 90 | 2011 | Alicia Grande Vice President, Treasurer and CFO | 159.7K | 4.8K | — | — | — | 6.4K | 242.2K | 0.00% | ↗ |
| 91 | 2010 | Patrick J. McEnany Chairman, President and CEO | 357.7K | — | — | — | — | — | 413.9K | 0.00% | ↗ |
| 92 | 2010 | Patrick J. McEnany Chairman, President and CEO | 357.7K | — | — | — | — | — | 413.9K | 0.00% | ↗ |
| 93 | 2010 | Steven R. Miller, Chief Operating Officer and Chief Scientific Officer | 230.0K | 20.0K | — | — | — | 9.2K | 304.2K | 0.00% | ↗ |
| 94 | 2010 | Steven R. Miller, Ph.D. COO and CSO | 230.0K | 20.0K | — | — | — | 9.2K | 304.2K | 0.00% | ↗ |
| 95 | 2010 | Steven R. Miller Chief Operating Officer and Chief Scientific Officer | 230.0K | 20.0K | — | — | — | 9.2K | 304.2K | 0.00% | ↗ |
| 96 | 2010 | Jack Weinstein CFO, Treasurer and VP, Business Development | 227.1K | — | — | — | — | 9.1K | 281.2K | 0.00% | ↗ |
| 97 | 2010 | Alicia Grande Vice President, Treasurer and CFO | 155.0K | — | — | — | — | 6.2K | 191.2K | 0.00% | ↗ |
| 98 | 2010 | Alicia Grande Vice President, Treasurer and CFO | 155.0K | — | — | — | — | 6.2K | 191.2K | 0.00% | ↗ |
| 99 | 2009 | Patrick J. McEnany Chairman, President and CEO | 347.2K | — | — | — | — | — | 434.4K | 0.00% | ↗ |
| 100 | 2009 | Steven R. Miller, Ph.D. COO and CSO | 204.3K | 15.0K | — | — | — | 8.3K | 310.2K | 0.00% | ↗ |
| 101 | 2009 | Steven R. Miller, Chief Operating Officer and Chief Scientific Officer | 204.3K | 15.0K | — | — | — | 8.3K | 310.2K | 0.00% | ↗ |
| 102 | 2009 | Jack Weinstein CFO, Treasurer and VP, Business Development | 220.5K | — | — | — | — | 8.8K | 301.2K | 0.00% | ↗ |
| 103 | 2009 | M. Douglas Winship, VP of Regulatory Operations | 198.4K | — | — | — | — | 7.8K | 258.4K | 0.00% | ↗ |
| 104 | 2009 | Alicia Grande Vice President, Treasurer and CFO | 149.2K | — | — | — | — | 5.9K | 202.0K | 0.00% | ↗ |
| 105 | 2008 | M. Douglas Winship, VP of Regulatory Operations | 186.8K | — | — | — | 9.3K | 7.4K | 410.7K | 0.00% | ↗ |
| 106 | 2008 | Patrick J. McEnany Chairman, President and CEO | 326.9K | 16.2K | — | — | — | — | 362.7K | 0.00% | ↗ |
| 107 | 2008 | Steven R. Miller, VP of Pharmaceutical Development and Project Management | 186.8K | — | — | — | 34.3K | 7.4K | 335.9K | 0.00% | ↗ |
| 108 | 2008 | Steven R. Miller, Ph.D. COO and CSO | 186.8K | 34.3K | — | — | — | 7.4K | 248.1K | 0.00% | ↗ |
| 109 | 2008 | Jack Weinstein CFO, Treasurer and VP, Business Development | 207.6K | 10.3K | — | — | — | 8.2K | 245.7K | 0.00% | ↗ |
| 110 | 2007 | M. Douglas Winship, VP of Regulatory Operations | 180.7K | — | — | — | — | — | 368.3K | 0.00% | ↗ |
| 111 | 2007 | Patrick J. McEnany Chairman, President and CEO | 316.2K | — | — | — | — | — | 320.9K | 0.00% | ↗ |
| 112 | 2007 | Steven R. Miller, VP of Pharmaceutical Development and Project Management | 134.3K | — | — | — | — | — | 286.3K | 0.00% | ↗ |
| 113 | 2007 | Alicia Grande Corporate Controller and CAO | 132.9K | — | — | — | 9.5K | — | 208.9K | 0.00% | ↗ |
| 114 | 2007 | Jack Weinstein Vice President, Treasurer and CFO | 200.8K | — | — | — | — | — | 203.8K | 0.00% | ↗ |
| 115 | 2006 | Jack Weinstein Vice President, Treasurer and CFO | 97.6K | — | — | — | 140.6K | — | 1.01M | 0.00% | ↗ |
| 116 | 2006 | M. Douglas Winship Vice President of Regulatory Operations | 86.5K | — | — | — | — | 23.9K | 850.3K | 0.00% | ↗ |
| 117 | 2006 | M. Douglas Winship, VP of Regulatory Operations | 86.5K | — | — | — | — | 23.9K | 202.9K | 0.00% | ↗ |
| 118 | 2006 | Patrick J. McEnany Chairman, President and CEO | 133.2K | — | — | — | — | — | 133.2K | 0.00% | ↗ |
| 119 | 2005 | Patrick J. McEnany Chairman, President and CEO | 83.3K | — | — | — | — | — | 553.3K | 0.00% | ↗ |
| 120 | 2005 | Jack Weinstein Vice President, Treasurer and CFO | 60.0K | — | — | — | — | — | 379.5K | 0.00% | ↗ |
| 121 | 2004 | Jack Weinstein Vice President, Treasurer and CFO | 15.2K | — | — | — | — | — | 234.2K | 0.00% | ↗ |
| 122 | 2004 | Patrick J. McEnany Chairman, President and CEO | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Richard John Daly | President, Chief Executive Officer & Director | 1M | male |
| Michael W. Kalb | Executive Vice President, Treasurer & Chief Financial Officer | 996.8K | male |
| Steven R. Miller | Executive Vice President, Chief Operating Officer & Chief Scientific Officer | 926.6K | — |
| Jeffrey Del Carmen | Executive Vice President & Chief Commercial Officer | 863.0K | male |
| Preethi Sundaram | Chief Strategy Officer | 753.4K | — |
| Brian Elsbernd | Chief Compliance Officer & Chief Legal Officer | 311.4K | male |
| Patrick J. McEnany | Co-Founder & Non-Executive Chairman | 282.2K | male |
| Paul Friel | Executive Vice President of Corporate Operations | — | male |
| Mary Coleman | Vice President & Head of Investor Relations | — | female |
| Gregg Russo | Chief Human Resources Officer | — | male |
| William T. Andrews FACP | Chief Medical Officer | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CPRX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
